Aaron Anderson has extensive experience in pharmaceutical sales, particularly in oncology and various specialty markets. At Genentech, from April 2017 to March 2020, Aaron successfully promoted Tecentriq for lung and urothelial carcinoma. Following this, a position as Senior Oncology Specialist at Eisai US from March 2020 to October 2022 focused on Lenvima. Currently, since October 2022, Aaron serves as an Oncology Account Specialist at AstraZeneca. Prior to these roles, Aaron held various positions at Amgen and Merck, where responsibilities included promoting specific medications across rheumatology, dermatology, and several therapeutic areas. Aaron earned a Bachelor's degree in Education from Canisius College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices